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ABSTRACT
Obesity, which underlies various metabolic and cardio-
vascular diseases, is a growing public health challenge
for which established therapies are inadequate. Given
the current obesity epidemic, there is a pressing need
for more novel therapeutic strategies that will help adult
individuals to manage their weight. One promising
therapeutic intervention for reducing obesity is to
enhance energy expenditure. Investigations into human
brown fat and the recently discovered beige/brite fat
have galvanized intense research efforts during the past
decade because of their pivotal roles in energy dissi-
pation. In this review, we summarize the evolution of
human brown adipose tissue (hBAT) research and dis-
cuss new in vivo methodologies for evaluating energy
expenditure in patients. We highlight the differences
between human and mouse BAT by integrating and
comparing their cellular morphology, function, and gene
expression proﬁles. Although great advances in hBAT
biology have been achieved in the past decade, more
cellular models are needed to acquire a better under-
standing of adipose-speciﬁc processes and molecular
mechanisms. Thus, this review also describes the
development of a human brown fat cell line, which could
provide promising mechanistic insights into hBAT
function, signal transduction, and development. Finally,
we focus on the therapeutic potential and current limi-
tations of hBAT as an anti-glycemic, anti-lipidemic, and
weight loss-inducing ‘metabolic panacea’.
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INTRODUCTION
Throughout human history, cold weather and famine were
threats to survival. To ward off these threats, brown adipose
tissue (BAT) and white adipose tissue (WAT) were evolu-
tionarily selected. BAT dissipates energy to keep us warm,
while WAT stores excess energy to be spent during times of
food deﬁciency. These two complementary fat depots work to
maintain energy balance. However, industrialization and
technological advancements in developed societies have
broken this balance due to an increase in sedentary occu-
pations, overabundance of food, lack of physical activity, and
warm shelter, causing obesity rates to skyrocket as more
countries move from being undeveloped to developed. As the
World Health Organization (WHO) reported in June 2016,
worldwide obesity has more than doubled since 1980 (World
Health Organization Fact Sheets: Obesity and Overweight,
2016). In 2014, 39% of adults aged 18 years and older were
overweight, and 13% of them were obese (World Health
Organization Fact Sheets: Obesity and Overweight, 2016).
Most of the world’s population lives in countries where a high
body mass index kills more people than a low one (World
Health Organization Fact Sheets: Obesity and Overweight,
2016). In other words, food shortages have not been as
deadly as food surpluses. According to the data, obesity,
which is associated with type 2 diabetes, polycystic ovarian
syndrome, hypertension, cardiovascular disease, etc., is the
major public health challenge of the 21st century (Eckel et al.,
2010). Thus, therapeutic approaches that prevent and/or
reverse obesity deserve further exploration.
Brown adipocytes, which are rich in mitochondria, are dif-
ferent from white adipocytes because they consume energy
more efﬁciently. Indeed, increased energy expenditure would











be expected to reverse and/or prevent obesity (Hall et al.,
2011). Given that active BAT with energy dissipation function
has been conﬁrmed in a number of humanadults (Nedergaard
et al., 2007; Cypess et al., 2009; Saito et al., 2009; vanMarken
Lichtenbelt et al., 2009), research interests into humanBATas
ameans of controlling obesity by diverting excess fat into heat
has greatly intensiﬁed and represents a novel therapeutic
approach for combatting this deadly, metabolic disease.
THE EVOLUTION OF HUMAN BAT RESEARCH
In 1902, Shinkishi Hatai ﬁrst reported in a human embryonic
development study that BAT is located beneath the stern-
ocleidomastoid and trapezius muscles and runs laterally and
parallel to the neck (Hatai, 1902). During human infancy,
heat is generated by BAT via non-shivering thermogenesis,
which is the main defense our bodies employ against cold
environments (Aherne and Hull, 1966). With increasing age,
human brown adipose tissue (hBAT) was thought to diminish
and ultimately vanish. It was not until his 1972 necropsy
study that Heaton found human BAT persists throughout
later stages of life, located at speciﬁc anatomical locations
including around the kidneys, suprarenals and aorta, and in
the neck and mediastinum (Heaton, 1972). In the 1980s,
Huttunen et al. found that a large proportion of fat cells iso-
lated from the neck contained potent mitochondrial enzymes
in adult individuals exposed to cold (Huttunen et al., 1981).
No active BAT had been identiﬁed in human adults prior to
these discoveries because in vivo research into hBAT was
severely hampered by a lack of methodologies that could
accurately pinpoint its location.
In the mid-1990s, the emergence of positron emission
tomography (PET) using the glucose tracer, 2-[18F]-ﬂuoro-
D-2-deoxy-D-glucose (FDG), combined with computer
tomography (CT) renewed interest in hBAT and its role in
energy expenditure (Cypess et al., 2009; Saito et al., 2009;
van Marken Lichtenbelt et al., 2009). Just as in malignancy,
hyper-metabolic hBAT has a high FDG uptake rate that can
be detected by the minimally-invasive PET-CT technique
in vivo. More recently, it has been discovered that a signiﬁ-
cant number of adult humans have active BAT that can be
detected by PET-CT (Cypess et al., 2009; Saito et al., 2009;
van Marken Lichtenbelt et al., 2009). However, PET-CT is
not sensitive to BAT in the thermoneutral state because it
depends on tissue glucose utilization (Chen et al., 2013). In
recent years, magnetic resonance imaging (MRI) and func-
tional (f)MRI, which detect changes associated with blood
ﬂow, have been used to assess hBAT volume and monitor
responses to certain stimuli. MRI distinguishes between BAT
and WATaccording to three physiological criteria: BAT has a
higher water-to-fat ratio, a higher density of mitochondria,
and more blood vessels than WAT (Chen et al., 2013).
According to imaging examinations, the main BAT depots
are in the supraclavicular and neck regions with some
additional paravertebral, mediastinal, para-aortic, and
suprarenal localization (but not the interscapular region)
(Nedergaard et al., 2007), which coincide with former
anatomical results.
Great advances about hBAT biology have emerged from
imaging methods in recent years, and many of the
achievements concur with those of murine BAT. Based on a
higher FDG uptake, PET-CT scans showed that cold expo-
sure signiﬁcantly enhances hBAT activation (Saito et al.,
2009; van Marken Lichtenbelt et al., 2009). Gender is
another key determinant of BAT mass and activity. In gen-
eral, women contain more BAT than men, while BAT distri-
butions are similar across sexes (Cypess et al., 2009).
Moreover, BAT volume and cold-activated FDG uptake are
inversely correlated with age, beta-blocker use, body-mass
index, body fat, and visceral fat (Nedergaard et al., 2007;
Cypess et al., 2009; Saito et al., 2009). Thus, BAT is more
abundant in younger and leaner individuals and decreased
by long-term beta-blocker use. Altogether, these novel
approaches have signiﬁcantly advanced our understanding
about hBAT localization and regulatory function and have
provided researchers with the necessary tools to assess
BAT’s therapeutic potential in treating human obesity.
MORPHOLOGICAL, FUNCTIONAL, AND GENETIC
DIFFERENCES BETWEEN BAT AND WAT IN
HUMANS
Compared to WAT, human BAT is highly vascularized and
contains more non-medullated nerve-ﬁbers, which gives it a
deeper color. BAT also plays an important role in energy
dissipation, whereas the propensity to store energy in WAT is
much higher since it can store excess calories as large,
intracellular triacylglycerol (TG) droplets; the fat droplets
from BAT on the other hand, are much smaller and contain
numerous, similar-sized locules, which are conducive to
rapid oxidation of lipids (Table 1). In the course of glucose
and fatty acid catabolism, the BAT marker UCP1 mediates
proton uncoupling over the inner mitochondrial membrane,
thereby converting fuel substrates into heat instead of ATP, a
process known as non-shivering thermogenesis (Daniel
Ricquier, 1976; Nicholls and Locke, 1984). However, no
UCP1 expression is detected in WAT (Virtanen et al., 2009).
During cold exposure, non-shivering thermogenesis stabi-
lizes core body temperature by consuming energy via
oxidative metabolism. To maintain energy levels, the glucose
uptake rate of hBAT is increased by a factor of 12, while
plasma insulin concentration is concurrently decreased and
hWAT is unaffected (Orava et al., 2011). For comparison,
insulin only enhances BAT glucose uptake 5-fold, whereas
the effect on WAT is even smaller (Orava et al., 2011). The
expression level of GLUT4, the insulin-responsive glucose
transporter, is higher in BAT than in WAT, an observation that
might underlie greater glucose uptake in BAT versus WAT
(Virtanen et al., 2009). Interestingly, glucose can induce
thermogenesis of hBAT in a sympathetic-independent man-
ner (Lee et al., 2016). These results provoke the hypothesis
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that converting WAT into BAT is a promising approach to
treat diabetes mellitus. However, the mechanisms of hBAT
glucose uptake are not well understood. UCP1, the BAT
marker gene, releases stored caloric energy as heat by
uncoupling protons produced by oxidative phosphorylation
(Cypess et al., 2009). The transcription factor PR domain
containing 16 (PRDM16) is a critical switch factor in deter-
mining the commitment of mouse Myf5+ precursors to brown
adipocytes versus myogenic cells (Jimenez-Preitner et al.,
2011; Kajimura et al., 2009). PRDM16 is more highly
expressed in hBAT than hWAT. Similarly, other BAT-related
mRNAs such as type 2 iodothyronine deiodinase (D2), per-
oxisome-proliferator-activated receptor g coactivator 1α
(PGC-1α), and β3-adrenergic receptor also occur at signiﬁ-
cantly higher levels in hBAT versus hWAT (Virtanen et al.,
2009). These results suggest that these genes play impor-
tant roles in promoting BAT development, and their function
in hBAT might emulate what is observed in mice.
IS ADULT HUMAN BAT A CLASSICAL BAT OR
BEIGE/BRITE ADIPOSE TISSUE?
Two distinct types of UCP1-positive adipocytes have been
identiﬁed in mice: the classical brown fat cells and brown-like
fat cells (also called beige or brite adipocytes) (Ishibashi and
Seale, 2010; Seale et al., 2008). Unlike classical brown fat,
which is derived from a myf-5 lineage (Seale et al., 2008),
beige cells in WATare derived from a non-myf-5 lineage and
share features of both white and brown fat cells, including
high expression of white adipocyte-speciﬁc markers (e.g.
aP2, adipsin, and PPAR-γ) (Ishibashi and Seale, 2010).
Adult hBAT, which is dispersed mainly in the supraclavicular,
para-aortic, and suprarenal regions and is densely inner-
vated, could be activated by cold through the sympathetic
nervous system (Cannon and Nedergaard, 2011; Lowell and
Spiegelman, 2000). However, unlike the classical brown
adipocytes found in the interscapular regions of rodents and
human infants, adult hBAT shares many molecular, histo-
logical, and functional characteristics with cold-induced
beige fat found in the sWAT of rodents (Wu et al., 2012; Qiu
et al., 2014). For example, mouse beige cells express
Slc27a1, TMEM26, TBX1, CD40, and CD137 in a beige-
selective manner, some of which, such as CD137, TMEM26,
and TBX1, are highly expressed in adult hBAT (Wu et al.,
2012), indicating that cold-induced hBAT is more closely
related to rodent beige fat rather than classical brown fat.
Within adult human neck BAT, the gene expression pattern
of superﬁcial neck fat resembles that of mouse sWAT, while
deep neck fat is more like mouse BAT with high UCP1,
PGC1-α, and D2 levels (Qiu et al., 2014). A whole-genome
microarray experiment showed that the best molecular
markers for grouping human fat cells are: 1) MPZL2,
HOXC9, EBF3, FBXO31, and LEP, as WAT markers; 2)
TNFRSF9, TMEM26, and SHOX2, as beige/brite markers;
and 3) UCP1, LHX8, and ZIC1, as BAT markers (Table 1)
(Cypess et al., 2013). Taken together, these studies suggest
that cold-induced activation of hBAT primarily involves beige
fat recruitment. However, more detailed work is needed to
determine whether cold-induced activation of hBAT is
mediated mainly by the sympathetic nervous system (SNS)








Cypess et al. (2009), Heaton (1972)
Cellular
morphology
Numerous, small lipid droplets Unilocular, large lipid droplets Heaton (1972)
Blood supply and
nerve-ﬁbers
Abundant Low Heaton (1972), Hatai (1902)
Regulatory
function
Dissipating energy as heat
production
Storing energy as triglycerides Smith and Roberts (1964)
Mitochondria Abundant Low Heaton (1972), Nicholls and Locke
(1984)
UCP1 High Nearly undetectable Virtanen et al. (2009), Svensson
et al. (2011)
Biomarkers UCP1, LHX8, and ZIC1, MPZL2, HOXC9, EBF3,
FBXO31, and LEP,
Cypess et al. (2013)
Insulin sensitivity High Low Orava et al. (2011)
Activators Cold, exercise High-calorie diet Saito et al. (2009), Orava et al.
(2011), Carriere et al. (2014)
Obesity and type
2 diabetes
Negative effect Positive effect Eger (1954), Himms-Hagen (1979)
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or by alternative activation of the eosinophils-type 2 cyto-
kine-macrophage signaling pathway (Qiu et al., 2014), or
both.
DISTINCTION OF HUMAN BAT AND MOUSE BAT
Much of our knowledge about BAT is based on mouse
studies and thus, it is of great interest to compare function-
ality, gene, and protein expression of mouse and human
BAT. However, the principal rodent BAT depot lies in a well-
deﬁned anatomical location and is homogeneously com-
posed of brown adipocytes, whereas hBAT is widely dis-
persed and occurs as a mixture of white, classical brown,
and recruitable brite adipocytes (Jespersen et al., 2013)
(Table 2). Comparison of microRNA expression proﬁles
between mouse and human BAT reveals that while 145
miRNAs are expressed in both species, at least 250 other
miRNAs are expressed exclusively in one species or the
other (Guller et al., 2015). It is important to note too that the
homology between mouse and human UCP1 is less than
80%, suggesting there may be functional differences
between species (Hughes et al., 2009). In addition, rodent
UCP1 kinetics have been extensively studied in a variety of
expression systems, whereas no corresponding study on
human UCP1 kinetics has been reported to date (Hirschberg
et al., 2011). Regarding thermogenic signal transduction,
murine BAT is profoundly activated by selective β3 adren-
ergic agonists (Feldmann et al., 2009). In human studies,
treatment with the β3 adrenergic agonist, mirabegron, or
non-selective beta-blocker, propranolol, stimulated and
impaired FDG uptake, respectively (Feldmann et al., 2009;
van Baak et al., 2002). These reports suggest that β3
adrenergic receptor signaling is capable of boosting hBAT
metabolic activity. Nevertheless, there have been some
conﬂicting reports suggesting the β3 adrenergic response is
very weak or non-responsive in hBAT; it has been suggested
this is mainly due to sequence differences between the
rodent and human receptors as well as low efﬁcacy of the
human β3-adrenergic receptor in adipose tissue and poor
drug bioavailability (van Baak et al., 2002) (Table 2). A very
recent study also showed that glucocorticoids can acutely
increase isoprenaline-stimulated respiration and UCP1
expression in human primary brown adipocytes, but sub-
stantially decrease isoprenaline-stimulated respiration and
UCP1 in mouse primary brown adipocytes (Ramage et al.,
2016) (Table 2), again suggesting the presence of species-
speciﬁc differences between human and mouse BAT. More
prospective studies would be of great value for future
delineation of the difference between human and mouse
BAT biology.
MECHANISTIC EFFECTS OF AMBIENT
TEMPERATURE ON HBAT
Cold exposure profoundly enhances hBAT perfusion and
activity, and improves glucose and fatty acid uptake, thereby
supporting cold-induced energy dissipation (Saito et al., 2009;
Orava et al., 2011). These observations reveal hBAT as an
attractive target for treating and preventing obesity. However,
the promoting effect of cold-exposure on energy expenditure
is markedly suppressed by fasting-induced insulin resistance
(Hanssen et al., 2015). Rodents studies show that the stimu-
latory effects of cold exposure are emulated by electrical
stimulation of sympathetic nerves within BAT and by admin-
istration of adrenergic agonists, but abolished by surgical
severing of the sympathetic nerves or adrenergic blocker
treatment (Shimizu et al., 1991), indicating that cold-exposure
stimulates BAT via sympathetic nerves. However, the mech-
anism by which the SNS regulates hBAT upon cold-exposure
is still unknown. Agents that activate the SNS failed to activate
BAT in human studies, presumably due to the systemic effects
of SNS agonists and minimal BAT responsiveness (Cypess
et al., 2012). Epinephrine, a sympathomimetic drug, does not
activate hBAT at a dose that leads to broad activation of the
SNS (Cypess et al., 2012), suggesting that cold-exposure
activates speciﬁc sympathetic pathways responsible for hBAT
Table 2. Differences between human and mouse adipocytes
Human BAT Murine BAT Ref.
Distribution Dispersed The main BAT depots are in
well-deﬁned anatomic sites
Heaton (1972), Jespersen et al.
(2013)
Cell composition A mix of white, classical brown,
and recruitable brite adipocytes
Homogeneously composed of
brown adipocytes
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activation. In addition, most known effectors of UCP1-de-
pendent thermogenesis such as certain neuropeptides, leptin,
and capsaicin all converge on SNS activation. One of the
major drawbacks with using broad sympathetic activation to
stimulate thermogenesis however, are the serious-sideeffects
and increased risk for heart attack (Bonet et al., 2013).
Although cold exposure profoundly increases plasma con-
centrations of SNS activation biomarkers like norepinephrine
and the secondary messenger, cyclic adenosine monophos-
phate (cAMP), this effect has been found in humans both with
and without cold-activated BAT (Orava et al., 2011). In addi-
tion, stimulation of the parasympathetic vagus nerve also
increases energy expenditure in human BAT, although the
mechanism is unclear (Vijgen et al., 2013). These reports
suggest that hBAT stimulation through generalized sympath-
omimetic drugs is not a viable approach and thus, more
extensive analyses in human BATare needed.
Cold exposure may also alter human physiology by cross-
talking with immune cells to release cytokines capable of
inducing fat browning. In mice, cold exposure rapidly pro-
moted eosinophil-dependent and interleukin 4 (IL-4)-stimu-
lated alternative activation of adipose macrophages, which
secrete catecholamines to induce thermogenic gene
expression and/or lipolysis in both BAT and WAT (Qiu et al.,
2014; Nguyen et al., 2011). ILC2s can promote the eosino-
phil/IL-4Rα/alternatively-activated macrophage (AAMac)
(Qiu et al., 2014; Liu et al., 2014; Wu et al., 2011). Besides,
ILC2s have been shown to promote beiging in an IL33-de-
pend pathway in part via production of enkephalin peptides
that elicit beiging (Brestoff et al., 2015). IL-4 stimulation of
human monocytes has also been reported to promote
alternative activation, catecholamine production, lipolytic
activity of adipocytes, and dysregulated ILC2 responses in
WATare a conserved feature of obesity in humans and mice
(Brestoff et al., 2015), suggesting these pathways may play
the same roles across species (Nguyen et al., 2011). In
humans, mild cold exposure increases plasma levels of
ﬁbroblast growth factor-21 (FGF-21) (Lee et al., 2013), a
hormone that promotes systemic glucose uptake and oxi-
dation. In hBAT, FGF-21 expression positively correlates
with UCP1 expression, promotes BAT activity and recruits
inducible brown adipocytes via autocrine and/or endocrine
mechanisms (Hondares et al., 2014). Future studies aiming
to identify secreted factors that promote thermogenesis and/
or beiging will undoubtedly advance our understanding
about thermogenic regulation and may lead to novel anti-
obesity drug treatments.
EFFECTS OF EXERCISE ON HBAT ACTIVITY AND
THE UNDERLYING MECHANISMS
Exercise could produce energetic beneﬁts much greater
than the direct calories cost (Speakman and Selman, 2003).
Irisin, a myokine that upregulates human brown adipocyte
gene expression and thermogenesis in human neck
adipocytes, was found to be enhanced by exercise in
humans (Bostrom et al., 2012; Lee et al., 2014). Interestingly,
cold-induced shivering by muscle contraction stimulates iri-
sin secretion to levels that are nearly comparable to those
induced by exercise (Lee et al., 2014), suggesting that irisin
may link exercise to cold-induced thermogenesis and pro-
mote browning of human neck adipocytes and thermogen-
esis in concert with FGF21 during cold-exposure (Lee et al.,
2014) (Fig. 1). However, another study showed that neither
acute nor regular exercise altered irisin levels, although the
intensity of habitual physical activity, muscle volume,
strength, contractility are positively associated with circulat-
ing irisin (Kurdiova et al., 2014). Thus, it remains to be further
determined as to whether irisin regulates thermogenesis in
humans. Besides irisin, increased plasma lactate concen-
trations resulting from strenuous exercise may also con-
tribute to browning. Lactate, which is a glycolytic waste
product, drives the browning of human white adipocytes
through drastic and rapid inductions of several brown-adi-
pocyte genes including UCP1 via peroxisome proliferator







Figure 1. The mechanisms by which cold, exercise,
and obesity regulate thermogenesis. Cold exposure
could improve browning and thermogenesis of human
adipocytes through macrophages, sympathetic nervous
system (SNS), and muscle contraction. Cold exposure
rapidly promoted alternative activation of adipose tissue
resident macrophages, leading to the secretion of cate-
cholamines to induce beige fat development and thermo-
genesis. Cold activates the SNS, leading to the
upregulation of ﬁbroblast growth factor 21 (FGF21). Cold
and exercise cause muscle contraction, which stimulates
irisin secretion and induces shivering thermogenesis. In
response to cold-exposure, the shivering-induced irisin
promotes browning and thermogenesis of human adipo-
cytes in concert with the SNS-induced FGF21. Exercise is
also able to promote browning and thermogenesis by
increasing lactate production. In obese individuals,
enhanced lactate in adipocytes promotes browning and
thermogenesis of neighboring adipocytes, which in turn,
limits the accumulation of fat, thereby impeding the
development of obesity.
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activated receptor-γ (PPAR-γ), a master transcription factor
regulating adipocyte differentiation (Carriere et al., 2014).
Furthermore, obesity elevates lactate production in rat WAT
due to hypoxia (DiGirolamo et al., 1992). The lactate then
stimulates “browning” of neighboring white adipocytes
through an autocrine/paracrine effect. This could reﬂect a
self-regulatory response to limit the accumulation of fat
during obesity (Trayhurn and Alomar, 2015). Indeed, fat cells
cultured from obese or diabetic humans metabolize more
lactate than lean individuals (DiGirolamo et al., 1992), which
indicates that lactate might play the same role in vivo.
Human natriuretic peptides (NPs) also play a physiological
role in exercise-induced lipolysis (Moro et al., 2008). In hu-
man adipocytes, atrial natriuretic peptide (ANP) and brain
natriuretic peptide (BNP) induce a brown-like adaptive ther-
mogenic response by activating PPARγ coactivator-1α
(PGC-1α) and UCP1 expression and stimulating mitochon-
drial biogenesis, thereby increasing uncoupled and total
respiration (Bordicchia et al., 2012). Beyond the calories
burned at the gym, it is becoming increasingly clear that
changes in both gene expression and the secretome are
likely responsible for at least some of the beneﬁcial effects of
exercise on whole body energy expenditure (Speakman and
Selman, 2003).
REGULATORY FACTORS OF HUMAN BAT
Human brown adipocytes are regulated by many intrinsic
factors, including glucocorticoids and bile acids. In the
absence of glucocorticoids, brown adipocytes differentiate
poorly, particularly during early differentiation. Glucocorti-
coids induce PPAR-γ and CCAAT/enhancer binding pro-
tein-β (C/EBP-β) expression as well as increase PGC1-α
and GLUT-4 levels, while reducing the expression of DNA
binding-2 inhibitor (Id2) and TNF-α (Ramage et al., 2016;
Zilberfarb et al., 2001). Acute treatment of human brown
adipocytes with glucocorticoids at physiological concen-
trations increased basal and adrenergic stimulated respi-
ration and UCP1 expression (Ramage et al., 2016).
However, chronic glucocorticoid stimulation also sup-
pressed β-adrenergic thermogenesis in hBAT (Ramage
et al., 2016; Barclay et al., 2015), which may underlie glu-
cocorticoid therapy-associated body-weight gain. The bile
acid, chenodeoxycholic acid (CDCA), is another steroid
molecule that is essential for metabolism and thought to
increase human whole-body energy expenditure. In human
brown adipocytes, CDCA improves mitochondrial uncou-
pling and D2 expression via a G protein-coupled receptor
TGR5 (G-protein coupled receptor for bile acids)-depen-
dent mechanism (Broeders et al., 2015). As a registered
and generally recognized safe drug for humans (Broeders
et al., 2015), CDCA is a promising candidate to activate
hBAT and counter obesity and its related metabolic dis-
eases. Thus, identiﬁcation of more endogenous regulatory
factors is critically needed to elucidate hBAT biology and
the body’s complex responses to regulate energy
expenditure.
DEVELOPMENT OF IMMORTALIZED HUMAN
BROWN ADIPOCYTES
Despite advances in our understanding of murine BAT, there
remain numerous knowledge gaps concerning the biological
mechanisms of hBAT. Although thermal imaging and FDG/
MRI scans are capable of capturing human BATactivity non-
invasively, for in vitro research, human cell lines are still
needed to uncover the genetic, pharmacological, and envi-
ronmental determinants of BAT biological functions. PAZ6,
the ﬁrst available immortalized human BAT cell line (Zilber-
farb et al., 1997), has been used to study generic cellular
processes and evaluate the expression of adipogenic
markers. Differentiated PAZ6 adipocytes express a myriad of
brown adipocyte markers including β1, β2, and β3 adren-
ergic receptors (β-AR), α2A-AR, lipoprotein lipase, hormone
sensitive lipase, adipsin, the glucose transporters Glut 1 and
Glut 4, leptin, and UCP1 (Zilberfarb et al., 1997). Among
these BAT markers, the expression of leptin and GLUT1 is
markedly stimulated by hypoxia (Grosfeld et al., 2002),
which could be an adaptive mechanism that promotes
angiogenesis and increases adipose tissue oxygenation
(Grosfeld et al., 2002). While it is widely accepted that the
rodent β3-adrenoceptor is essential for regulating fat meta-
bolism, its role in human BAT is still under debate (Arch and
Wilson, 1996). According to a saturation binding analysis
using PAZ6 adipocytes, the β3-AR appears to be the most
abundant β-AR subtype. The selective β3-AR agonist, CGP
12177A, markedly increases cAMP concentration and lipol-
ysis activity in PAZ6 adipocytes (Zilberfarb et al., 1997). Pre-
treating PAZ6 adipocytes with norepinephrine however,
down-regulates β-AR number and desensitizes β3-AR sig-
naling (Jockers et al., 1998). These results suggest that β3-
AR in human brown adipocyte is functionally coupled to
lipolysis (Jockers et al., 1998). Thiazolidinediones are a
popular class of drugs used to treat type 2 diabetes because
of their ability to increase insulin sensitivity by binding to
PPAR-γ, which alters the expression of genes involved in
glucose and lipid metabolism. PAZ6 cells treated with thia-
zolidinediones exhibited enhanced brown adipocyte differ-
entiation as demonstrated by increased triglyceride content
and adipocyte-speciﬁc gene expression, including aP2,
PPAR-γ, β3-AR, HSL, and UCP2 (Strobel et al., 1999). Other
small molecules thought to promote hBAT function such as
dehydroepiandrosterone (DHEA) and retinoic acid (RA)
have also been tested in PAZ6 cells. Serum concentrations
of DHEA, a steroid sex hormone precursor, inversely corre-
late with biomarkers of metabolic syndrome, indicating that
DHEA may modulate adipose tissue mass and function.
DHEA inhibits PAZ6 preadipocyte proliferation by blocking
the G1/S or G2/M transition. By contrast, UCP1 mRNA levels
are higher in PAZ6 cells differentiated in the presence of
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DHEA. The inhibitory effect on PAZ6 pre-adipocyte cell cycle
progression and the promoting effect on PAZ6 adipocyte
gene expression may represent a pro-adipogenic mecha-
nism (Rice et al., 2010). In PAZ6 adipocytes, retinoic acid
increases UCP1 gene expression in a PGC1α-dependent
way, while the PPARα-speciﬁc agonist, WY14643, failed to
regulate UCP1 gene expression without RA (Oberkoﬂer
et al., 2002). However, the mechanism by which RA regu-
lates hBAT in vivo remains uncertain.
SUMMARY AND FUTURE PERSPECTIVES
The therapeutic potential of hBAT as an anti-glycemic, anti-
lipidemic, and weight loss-inducing ‘metabolic panacea’ is
postulated by calculations showing that when fully activated,
63 grams of BAT would burn the energy-equivalence of 4.1
kilograms of WAT over the course of a year (Virtanen et al.,
2009). Considering its striking capacity for energy dissipa-
tion, the ﬁndings in hBAT are clinically valuable for guiding
future prevention strategies and treatments for obesity,
insulin resistance, and other related metabolic diseases (Hall
et al., 2011). Increasing human energy expenditure through
hBAT by cold-exposure (Cypess et al., 2009; Aherne and
Hull, 1966) and exercise (Lee et al., 2013; Hondares et al.,
2014) however, would require drastic changes in life style.
Considering the discomfort of cold exposure, exercise is
likely the preferred approach for enhancing hBAT activity.
The increased irisin and lactate concentrations that are
induced during exercise have been reported to promote
adipocyte browning remodeling and are potential approa-
ches for treating obesity without the exercise (Bostrom et al.,
2012; Carriere et al., 2014). Molecules such as FGF-21,
natriuretic peptides, and thyroid hormones have also been
suggested as potential drugs to counteract obesity and its
related metabolic diseases. The thyroid hormone, tri-
iodothyronine (T3), has been shown to profoundly promote
mitochondrial biogenesis and UCP1 expression in brown-
like fat cells as well as skeletal muscle and brown adipose
tissue (Crisan et al., 2008). Another anti-obesity strategy that
has not been considered in this review, but warrant serious
investigation, includes transforming muscles cells into brown
fat. Interestingly, a stationary population of human skeletal
muscle cells expressing the CD34 surface protein have been
found to differentiate in vitro into genuine brown adipocytes
with a high level of UCP1 expression (Crisan et al., 2008),
suggesting that human skeletal muscle cells have the
potential to transdifferentiate into brown adipocytes. Thus,
ﬁnding new ways to reprogram skeletal muscle into brown fat
represents another novel approach to promote thermogen-
esis and combat obesity.
Although pharmacological means to treat obesity are
possible, supraphysiological concentrations of these medi-
cations are associated with severe side effects. In addition,
only a few defects in human BAT development and ther-
mogenesis due to gene mutations have been described
(Yoneshiro et al., 2005) thus, a better understanding of the
physiological processes underlying hBAT is still required
before BAT-related therapies can be developed. At present,
much of our knowledge about BAT is based on mouse
studies and hBAT research is still limited by a number of
factors such as access to high-quality, ethically-approved
clinical samples, reliable methods for measuring BAT vol-
ume and activity, and better ways to stimulate BAT function
with minimal adverse effects. One protocol, which collects
both MRI and 18F-FDG PET-CTscans, has been reported to
give accurate estimates of hBAT imaging volumes (Gifford
et al., 2015). In the future, this approach could be used in
longitudinal studies to assess therapeutic interventions. In
conclusion, we opine that a better understanding of hBAT
physiology will lead to new pharmacological targets for
treating obesity, and given the current obesity epidemic,
more physiological studies of brown adipose tissue in heal-
thy adult individuals are needed to fully characterize its
regulatory function and therapeutic potential.
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